Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Adhezion Biomedical
Safe and effective removal of cyanoacrylate vascular access catheter securement adhesive in neonates
Introduction Over recent years, evidence-based practice innovations, such as care bundles, and intravenous (IV) team approaches have become firmly embedded in neonatal vascular access (VA) practice (1–4). These developments have taken place alongside technological improvements in the design and manufacture of VA devices and catheters for neonatal patient populations, with the intent of reducing VA-related complications (5, 6).
Clinicians at 2022 AVA Scientific Meeting Discuss Observed Original
MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- At the 2022 Association for Vascular Access ("AVA") Annual Scientific Meeting, clinicians reported statistically significant reductions in dressing changes and Central Line-Associated Bloodstream Infections ("CLABSI") as a result of utilizing Adhezion Biomedical's SecurePortIV® Catheter Securement Adhesive. These findings were presented by clinicians representing seven separate institutions throughout the conference.
Clinicians at 2022 AVA Scientific Meeting Discuss Observed CLABSI-Reductions With SecurePortIV® Adhesive
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Press release content from Globe Newswire. The AP news staff was not involved in its creation. Clinicians at 2022 AVA Scientific Meeting Discuss Observed CLABSI-Reductions With SecurePortIV® Adhesive Adhezion Biomedical, LLCNovember 8, 2022 GMT MINNEAPOLIS, Nov.
2021 INS Standards Recognize SecurePortIV® Tissue Adhesive as Standard of Care
WYOMISSING, Pa., Jan. 19, 2021 /PRNewswire/ -- Adhezion Biomedical, LLC is excited to announce that the just-published 2021 Infusion Therapy Standards of Practice (INS Standards) recognizes tissue adhesive as a standard of care for all vascular access device (VAD) care and management. Adhezion Biomedical's SecurePortIV® is the only tissue adhesive cleared for this indication by the US FDA.
Adhezion_Biomedical.jpg
SecurePortIV sealing and securing an insertion site By Adhezion Biomedical, LLC;Infusion Therapy Standards of Practice; TownNews.com Content Exchange TownNews.com Content Exchange
Adhezion Biomedical introduces SecurePortIV
Adhezion Biomedical recently announces the 510(k) clearance of SecurePortIV catheter securement adhesive, a highly versatile cyanoacrylate formulation which can be used with short-term or long-term vascular access devices to enhance device securement, seal the catheter insertion site, protect the patient from catheter related blood stream infection, and provide a water-resistant barrier — all in a single product.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Adhezion
Contact Adhezion, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack